Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03410784
Title Pembrolizumab With Chemotherapy in Front Line Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer (MITO28MaNGOov4)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors National Cancer Institute, Naples

fallopian tube cancer

ovary epithelial cancer

peritoneal carcinoma


Carboplatin + Paclitaxel + Pembrolizumab

Age Groups: adult | senior
Covered Countries ITA

Facility Status City State Zip Country Details
Ospedale Generale Regionale "F. Miulli " Recruiting Acquaviva delle Fonti Italy Details
Istituto Tumori Giovanni Paolo II Recruiting Bari Italy Details
Spedali Civili - Università di Brescia Recruiting Brescia Italy Details
Ospedale Senatore Antonio Perrino Recruiting Brindisi Italy Details
Fondazione del Piemonte per l'Oncologia Recruiting Candiolo Italy Details
Istituto Romagnolo per lo Studio e la Cura dei Tumori Recruiting Meldola Italy Details
Istituto Nazionale Tumori Recruiting MIlano Italy Details
AOU Policlinico Federico II Recruiting Napoli Italy Details
AOU Università degli studi della Campania "Luigi Vanvitelli" Recruiting Napoli Italy Details
Istituto Nazionale dei Tumori Recruiting Napoli Italy Details
Ospedale Silvestrini Recruiting Perugia Italy Details
Ospedale S. Giovanni Calibita Fatebenefratelli Recruiting Roma Italy Details
Policlinico Universitario Gemelli Università Cattolica del Sacro Cuore Not yet recruiting Roma Italy Details
*Shaded cells indicate that there was no data available from for the field